Full Text View
Tabular View
No Study Results Posted
Related Studies
COmbined N-Acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT (CONTRAST)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by National University Hospital, Singapore.
Recruitment status was  Recruiting
Study NCT00497328   Information provided by National University Hospital, Singapore

First Received on July 4, 2007.   Last Updated on May 8, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Contrast Induced Nephropathy
Additional conditions recognized in this trial
Kidney Diseases
More general conditions related to this trial
Urologic Diseases
Interventions listed in this trial
N-acetylcysteine
Sodium Bicarbonate
Additional drug interventions recognized in this trial
Acetylcysteine
N-monoacetylcystine
More general drug interventions related to this trial
Anti-Infective Agents
Antidotes
Antioxidants
Antiviral Agents
Expectorants
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
National University Hospital, Singapore


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services